Results 61 to 70 of about 2,195 (197)

A critical appraisal of ‘Shingrix’, a novel herpes zoster subunit vaccine (HZ/Su or GSK1437173A) for varicella zoster virus

Human Vaccines & Immunotherapeutics, 2017
HZ/Su, branded as ‘Shingrix’, is one of the newest vaccines to be submitted for multi-national regulatory approval. It is targeted to prevent shingles, a global concern with aging populations. A live attenuated vaccine for shingles has been available for
Tehmina Bharucha, Damien Ming, Judith Breuer   +2 more
doaj   +1 more source

Global herpes zoster incidence, burden of disease, and vaccine availability: a narrative review

Therapeutic Advances in Vaccines and Immunotherapy, 2022
Herpes zoster (HZ) is a neurocutaneous disease that causes significant morbidity worldwide. The disease is caused by the reactivation of the varicella-zoster virus (VZV), which leads to the development of a painful, vesicular rash and can cause ...
Catherina X. Pan, Michelle S. Lee, Vinod E. Nambudiri   +2 more
doaj   +1 more source

Baculovirus Display of Varicella–Zoster Virus Glycoprotein E Induces Robust Humoral and Cellular Immune Responses in Mice

Viruses, 2022
Varicella–zoster virus (VZV) is the causative agent of varicella and herpes zoster (HZ) and can pose a significant challenge to human health globally. The initial VZV infection—more common in children—causes a self-limiting chicken pox. However, in later
Wenhui Xue, Tingting Li, Sibo Zhang, Yingbin Wang, Minqing Hong, Lingyan Cui, Hong Wang, Yuyun Zhang, Tingting Chen, Rui Zhu, Zhenqin Chen, Lizhi Zhou, Rongwei Zhang, Tong Cheng, Qingbing Zheng, Jun Zhang, Ying Gu, Ningshao Xia, Shaowei Li   +18 more
doaj   +1 more source

Comparative Cytokine and Histology Studies on HPV and Other Viral Vaccinations: No Pathogenicity of HPV Vaccine Adjuvants

Cancer Science, Volume 116, Issue 12, Page 3309-3325, December 2025.
Anti‐HPV vaccine activists claimed that aluminum (Al) adjuvants in HPV vaccines could cause immune abnormalities, leading to neurological diseases. We evaluated the cytokine and histology profiles following administrations of HPV vaccines and other viral vaccines containing adjuvants.
Reona Shiro, Fumitaka Sato, Seiichi Omura, Ah‐Mee Park, Cong Thanh Nguyen, Ijaz Ahmad, Sandesh Rimal, Koji Kinoshita, Noriomi Matsumura, Ikuo Tsunoda   +9 more
wiley   +1 more source

Herpes Zoster Recurrence: A Narrative Review of the Literature

Dermatology and Therapy
Introduction Herpes zoster (HZ; shingles) is a painful, cutaneous disease caused by reactivation of the varicella zoster virus, which causes varicella (chickenpox) typically during childhood.
Raunak Parikh, O’Mareen Spence, Nikolaos Giannelos, Iain Kaan   +3 more
doaj   +1 more source

Evaluatie van het Shingrix vaccin tegen ZONA

, 2022
Zona is een pijnlijke ziekte die veroorzaakt wordt door een reactivatie van het windpokkenvirus. In de meerderheid van de gevallen geneest zona spontaan binnen 2 à 4 weken. Maar er kunnen zich wel complicaties voordoen, zoals postherpetische neuralgie (10 à 20% van de gevallen van zona). Andere, mogelijk ernstigere, complicaties zijn zeldzamer.
Dominique, Roberfroid, Zeevaert, Renate, Maertens de Noordhout, Charline, Thiry, Nancy   +3 more
openaire   +1 more source

Shingrix Vaccine and Guillain-Barre syndrome: a case report

RRNMF Neuromuscular Journal, 2020
   
Werdah Zafar, Hunain Aslam, Lakshmi Digala, Raghav Govindarajan   +3 more
openaire   +2 more sources

Association Between Herpes Zoster and Risk of Incident Fragility Fractures in US Veterans: A Matched Cohort Study

Journal of the American Geriatrics Society, Volume 73, Issue 12, Page 3778-3788, December 2025.
Association between herpes zoster and risk of incident fragility fractures in US veterans: a matched cohort study. ABSTRACT Background Herpes zoster (HZ) and fragility fractures typically affect older adults and present major burdens to healthcare systems.
Calif A. A. Yousuf, Julie A. Womack, Roger J. Bedimo, Christopher T. Rentsch, Charlotte Warren‐Gash   +4 more
wiley   +1 more source

Shingrix Education for Providers [PDF]

, 2019
Shingles is a prevalent disease within the overall population, and incidence in North America continues to increase. Shingles is commonly found in older adults 60 years of age and older and can recur two or three times. Shingrix was released in 2017 as a
Buzzeo, Lindsey Hanks
core   +1 more source

Trained Immunity in Health and Disease

MedComm, Volume 6, Issue 11, November 2025.
Growth and timescale of medical publications on trained immunity and its related health and disease. This figure illustrates the number of published papers over time, from 2000 to 2025 (by August 14, 2025), related to trained immunity and its related health and disease.
Meng Yao, Jian Zhou, Jialun Mei, Chuan Gao, Peng Ding, Gan Li, Changqing Zhang, Zhiwei Li, Junjie Gao   +8 more
wiley   +1 more source